BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22515502)

  • 1. Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.
    Zhang B; Zhang Z; Zhang X; Gao X; Kernstine KH; Zhong L
    Biomarkers; 2012 Jun; 17(4):372-8. PubMed ID: 22515502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
    Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
    Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
    Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
    Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H
    Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
    Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
    Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
    Zhou JH; Zhang B; Kernstine KH; Zhong L
    World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
    Mizukami Y; Kono K; Daigo Y; Takano A; Tsunoda T; Kawaguchi Y; Nakamura Y; Fujii H
    Cancer Sci; 2008 Jul; 99(7):1448-54. PubMed ID: 18452554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
    Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.
    de A Simão T; Souza-Santos PT; de Oliveira DS; Bernardo V; Lima SC; Rapozo DC; Kruel CD; Faria PA; Ribeiro Pinto LF; Albano RM
    Exp Mol Pathol; 2011 Oct; 91(2):584-9. PubMed ID: 21777580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma.
    Iwahashi M; Katsuda M; Nakamori M; Nakamura M; Naka T; Ojima T; Iida T; Yamaue H
    Cancer Sci; 2010 Dec; 101(12):2510-7. PubMed ID: 20874827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
    Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
    Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
    Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
    Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma.
    Kuboshima M; Shimada H; Liu TL; Nakashima K; Nomura F; Takiguchi M; Hiwasa T; Ochiai T
    Int J Oncol; 2006 Feb; 28(2):463-8. PubMed ID: 16391802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.